Search - tctmd.com

Displaying 961 - 980 of 1740

Sort: Relevancy | Date

News Daily News

Meta-analysis Supports Endovascular Therapy for Acute Stroke

Nicole Lou

June 23, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

L.A. McKeown

June 22, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

News Daily News

Advantage of Radial PCI Most Apparent at Extremes of BMI

Caitlin E. Cox

June 05, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

BRS Strut Width Tied to Increased Periprocedural MI

June 02, 2015

News Opinion Editor's Corner

Editor's Corner: Beyond the Cath Lab

Caitlin E. Cox

June 01, 2015

News Daily News

Wide Variability in CAS Outcomes Across Hospitals Not Tied to Procedural Volume

May 27, 2015

News Conference News EuroPCR 2015

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Caitlin E. Cox

May 22, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Industry News

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

May 20, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

Advertisement

Meta-analysis Supports Endovascular Therapy for Acute Stroke

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Advantage of Radial PCI Most Apparent at Extremes of BMI

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

BRS Strut Width Tied to Increased Periprocedural MI

Editor's Corner: Beyond the Cath Lab

Wide Variability in CAS Outcomes Across Hospitals Not Tied to Procedural Volume

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Trials Explore the Potential of Biodegradable-Polymer Stents

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

Evolving DES Technology May Benefit Diabetic Patients

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content